Navarrete ZVM, Rosa DJ, de la Barrera FM, Díaz MM

Language: Spanish
References: 9
Page: 30-39
PDF size: 61.38 Kb.

ABSTRACT

Background: The awake tracheal intubation of patients is considered as the essential method to guarantee the access to the suspected difficult airway. In order to face this problem, new disposals as the Bonfils retromolar Intubation Fiberscope have been developed. Short action and easily evaluated analgesics such as Remifentanil constitute an excellent election to achieve this goal; nevertheless, its dosage is very important as it is not free of adverse effects.
Objectives: To determine the concentration of Remifentanil in plasma that guarantees an optimal analgo-sedation for the awake tracheal intubation of patients with the Bonfils retromolar Intubation Fiberscope.
Methods: A descriptive study was carried out at "Cira García" Central Clinic. The sample was composed by 12 patients that were scheduled for cervical spine surgery that required orotracheal intubation because of their inability to stretch the neck.
Results: The average time to achieve an adequate state of consciousness with the applied anaesthetic method was 14 ± 5,8 min. Oxygen saturation decreased to an average of 94,2 ± 5,8 %. The values of mean arterial blood pressure (MAP), cardiac frequency (CF) and expiratory rate (ER) were 100,7 ± 17 mmHg, 77,6 ± 9,8. min^-1 y 13,9 ±39 min^-1 respectively. Four patients had memories during the procedure and reported to be satisfied with it. The calculated plasma concentration (PC) of Remifentanil, also necessary to achieve adequate intubation conditions, was 0,0027 ± 0,005 μg/mL.
Conclusions: The use of Remifentanil in properly calculated doses to achieve the analgo-sedation effect to tackle the suspected difficult airway with the Bonfils retromolar Intubation Fiberscope for the wake tracheal intubation of patients was an adequate strategy.

REFERENCES

1. Practice Guidelines for Management of the Difficult Airway. An Update Report by the American Society of Anesthesiologist Task Force on Management of the Difficult Airway. Anesthesiology. 2003;98:1269-77.

2. Eberhart LH, Arndt C, Aust HJ, Kranke P, Zoremba M, Morin A. A simplified risk score to predict difficult intubation: development and prospective evaluation in 3763 patients. Eur J Anaesthesiol. 2010;27:935-40.

3. Gudzenko V, Bittner EA, Schmidt UH. Emergency airway management. Respiratory Care. 2010;55(8):1026-35.

4. Mingo OH, Ashpole KJ, Irving CI, Rucklidge MWM. Remifentanil sedation for awake fiberoptic intubation with limited application of local anaesthetic in patients for elective head and neck surgery. Anaesthesia.2008;63(10):1065-9.

5. Machata AM, Gonano Ch, Andrea H. Awake nasotracheal fiberoptic Intubation: Patient Comfort, Intubating Conditions, and Hemodynamic Stability During Conscius Sedation with Remifentanil. Anesth Analg. 2003;97:904-8.

6. Abramson SI, Holmes AA, Hagberg CA.. Awake insertion of the Bonfils Retromolar Intubation FiberscopeTM in five patients with anticipated difficult airways. Anesth Analg. 2008;106:1215-17.

7. Fodale V, Schifilti D, Praticò C, Santamaria B. Remifentanil and the brain. Acta Anesthesiol Scand. 2008;52:319-26.

8. Servin FS. Remifentanil: an update. Current Opinion in Anaesthesiology. 2003;16:367-72.

9. Andrea A, Andrea C, Lombardo F, Valeri R. The effect-site concentration of remifentanil blunting cardiovascular responses to tracheal intubation and skin incision during bispectral index-guided propofol anesthesia. Anesth Analg. 2005; 101:125-30.